Table 3. End points of the ICART procedure.
Variables | ID-1 | ID-2 | ID-3 | ID-4 | ID-5 | ID-6 | ID-7 | ID-8 |
Direct stenting | Y | Y | Y | Y | Y | Y | Y | Y |
Distal embolization | N | N | N | N | N | N | N | N |
Composite angiographic end-point (distal embolization, slow flow, or no reflow) | N | N | N | N | N | N | N | N |
No reflow | N | N | N | N | N | N | N | N |
Slow flow | N | N | N | N | N | N | N | N |
Side branch occlusion | N | N | N | N | N | N | N | N |
Hemorrhage | N | N | N | N | N | N | N | N |
Stroke | N | N | N | N | N | N | N | N |
CTFC post-PPCI | 13 | 8.82 | 9 | 10.58 | 17 | 19 | 13 | 7.05 |
Myocardial blush grade post-PPCI | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Peak of TnT mass, ng/mL | 31.2 | 0.185 | 4.09 | 6.59 | 33.1 | 3.33 | 14.8 | 5.7 |
Peak of NT Pro-BNP, pg/mL | 3667 | 46.18 | 1625 | 4784 | 1391 | 4738 | 511 | 632 |
CTFC: corrected thrombolysis in myocardial infarction frame count; ICART: intracoronary arterial retrograde thrombolysis; N: no; NT Pro-BNP: N-terminal pro-B-type natriuretic peptide; PPCI: primary percutaneous coronary intervention; TnT: troponin T; Y: yes.